☆ 4.0 Article

Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2023)

Related references

Note: Only part of the references are listed.

Article Respiratory System

European Respiratory Society guideline on various aspects of quality in lung cancer care

Torsten Gerriet Blum et al.

Summary: This guideline provides good quality recommendations in lung cancer care, based on systematic reviews and evidence syntheses. The recommendations cover various quality improvement measures, such as avoiding delays in diagnosis and treatment, integrating multidisciplinary teams, adhering to guidelines, and using specific tools for decision-making. The recommendations should be periodically updated as new evidence becomes available.

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection

Review Economics

Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations

Carina M. Behr et al.

Summary: Low-dose computed tomography (LDCT) is a promising technology for population-based screening due to its non-invasiveness, cost-effectiveness, low radiation, and high sensitivity to lung cancer. This systematic review analyzed studies on the cost-effectiveness of LDCT screening programs for various diseases.

PHARMACOECONOMICS (2023)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Important parameters for cost- effective implementation of lung cancer screening

Helen Morgan et al.

Summary: Low-dose computed tomography (LDCT) for lung cancer screening has been widely accepted for reducing late-stage diagnoses and mortality. However, the economic costs associated with screening need to be considered. Various health economic models have shown significant variation in cost per Quality-Adjusted Life Year (QALY), influenced by healthcare costs and modifiable program components. Recent studies using UK costs suggest most scenarios are within the willingness to pay threshold. Identifying the most clinically and cost-effective program is crucial, considering factors such as population selection, participation rate, screening intervals, nodule management, and clinical workup.

BRITISH JOURNAL OF RADIOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Lung Cancer Screening with Low-Dose CT: Radiation Risk and Benefit-Risk Assessment for Different Screening Scenarios

Elke A. Nekolla et al.

Summary: Recent studies have shown that low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in heavy smokers or ex-smokers. However, LDCT screening is associated with radiation risks, and the benefits and risks need to be carefully considered.

DIAGNOSTICS (2022)

Add to Collection

Article Oncology

The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials

Mengmeng Li et al.

Summary: This study aimed to understand the reasons behind the variations in estimates of overdiagnosis in low-dose computed tomography (LDCT) lung cancer screening trials. A systematic review was conducted to identify these estimates from randomized controlled trials of LDCT screening. The association between Ps (the excess incidence of lung cancer as a proportion of screen-detected cases) and postscreening follow-up time was analyzed. The results showed that differences in postscreening follow-up time could partially explain the variations in overdiagnosis estimates across trials. The findings emphasize the importance of considering postscreening follow-up and population characteristics when interpreting estimates of overdiagnosis.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Design and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography

Jens Vogel-Claussen et al.

Summary: Despite the high prevalence and mortality of lung cancer, Germany still lacks a national screening program. The German Institute for Quality and Efficiency in Health Care and the Federal Office for Radiation Protection both recommend a quality-controlled national screening program, emphasizing the importance of risk definition, smoking cessation programs, and quality assurance.

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2022)

Add to Collection

Review Medicine, General & Internal

Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality

Asha Bonney et al.

Summary: This study aimed to evaluate the effectiveness and possible harms of lung cancer screening using low-dose computed tomography (LDCT). The results showed that LDCT screening could reduce lung cancer-related mortality and all-cause mortality in high-risk populations. However, LDCT screening led to more invasive tests and false-positive results, and further trials are needed to determine the optimal frequency and duration of screening.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)

Add to Collection

Article Oncology

Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial

Sandra Gonzalez Maldonado et al.

Summary: A study on lung cancer screening among long-term smokers revealed a risk of overdiagnosis in the screening group, especially for individuals with shorter life expectancies. The excess cumulative incidence in the screening arm was largely driven by adenocarcinomas, suggesting a major risk of overdiagnosis for individuals with comparatively short remaining life expectancies.

INTERNATIONAL JOURNAL OF CANCER (2021)

Add to Collection

Article

Tabakentwöhnung - Strategien für die Praxis

Andrea Rabenstein et al.

MMW Fortschritte der Medizin (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting

Rudolf Kaaks et al.

Summary: Lung cancer screening should be targeted at individuals with elevated risk and sufficient residual life expectancy to ensure benefits outweigh risks.

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2021)

Add to Collection

Review Medicine, General & Internal

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

Alex H. Krist et al.

Summary: Lung cancer is the second most common cancer and leading cause of cancer death in the US, with smoking and increasing age being the primary risk factors. Annual screening with low-dose computed tomography is recommended for adults aged 50 to 80 years with a 20 pack-year smoking history.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Medicine, General & Internal

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography Modeling Study for the US Preventive Services Task Force

Rafael Meza et al.

Summary: The study modeled the benefits and harms of LDCT screening for lung cancer, finding that starting at age 50 or 55 with a smoking history of 20 pack-years or more had more benefits compared to the 2013 USPSTF recommendations, but also resulted in more false-positive results, overdiagnosed cases, and radiation-related lung cancer deaths.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Oncology

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening

Iakovos Toumazis et al.

Summary: The study found that the 2021 USPSTF recommendation for lung cancer screening was cost-effective compared to the 2013 recommendation, but expanding screening eligibility to include former smokers who have quit for more than 15 years may further improve cost-effectiveness. Alternative screening strategies with a minimum cumulative smoking exposure of 20 pack-years, including individuals who quit within the past 25 years, were found to be more cost-effective than the 2021 recommendation.

JAMA ONCOLOGY (2021)

Add to Collection

Article Oncology

Analysis of the baseline performance of five UK lung cancer screening programmes

Haval Balata et al.

Summary: The performance of UK-based lung cancer screening programmes, delivered within or aligned to the National Health Service, compares favorably to published clinical trial data. Reported harms, including false positive and benign surgical resection rates, are low. Ongoing monitoring of screening performance is vital to ensure standards are maintained and harms minimized.

LUNG CANCER (2021)

Add to Collection

Review Medicine, General & Internal

Lung Cancer Screening with Low-Dose CT in Smokers: A Systematic Review and Meta-Analysis

Theresa Hunger et al.

Summary: The review found that screening for lung cancer in (former) smokers with low-dose computed tomography (LDCT) can significantly reduce disease-specific mortality. However, the screening may have a high false positive rate and carries the risk of overdiagnosis.

DIAGNOSTICS (2021)

Add to Collection

Article Health Care Sciences & Services

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

John K. Field et al.

Summary: The UKLS trial showed that a single LDCT screening can significantly reduce lung cancer mortality, with results similar to the NELSON and NLST trials. The meta-analysis of nine randomized trials provided unequivocal support for lung cancer screening in identified risk groups.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Respiratory System

Quit attempts and tobacco abstinence in primary care patients: follow-up of a pragmatic, two-arm cluster randomised controlled trial on brief stop-smoking advice - ABC versus 5As

Sabrina Kastaun et al.

Summary: The study showed that patients who received advice from GPs had higher odds of attempting to quit smoking and achieving abstinence compared to those who did not receive advice, as confirmed by follow-up analysis of 1937 smoking patients.

ERJ OPEN RESEARCH (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Lung Cancer Screening by Low-Dose Computed Tomography Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting

Rudolf Kaaks et al.

Summary: Screening with LDCT can reduce lung cancer mortality by approximately 20%, but the risk of over-diagnosis may increase rapidly with age, particularly above 75. Below 50, the incidence of lung cancer may be too low for screening to provide a positive balance of benefits to harms and financial costs.

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2021)

Add to Collection

Article Oncology

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial

Nikolaus Becker et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

ESR/ERS statement paper on lung cancer screening

Hans-Ulrich Kauczor et al.

EUROPEAN RADIOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data

Anika Huesing et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Add to Collection

Article Respiratory System

Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester

Phil A. Crosbie et al.

THORAX (2019)

Add to Collection

Article Oncology

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U. Pastorino et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Review Public, Environmental & Occupational Health

Communication of cancer screening results by letter, telephone or in person: A mixed methods systematic review of the effect on attendee anxiety, understanding and preferences

Sian Williamson et al.

PREVENTIVE MEDICINE REPORTS (2019)

Add to Collection

Article Respiratory System

Joint Statement of the German Radiological Society and the German Respiratory Society on a Quality-Assured Early Detection Program for Lung Cancer with Low-dose CT

F. J. F. Herth et al.

PNEUMOLOGIE (2019)

Add to Collection

Article Oncology

Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach

Florian Hofer et al.

LUNG CANCER (2018)

Add to Collection

Article Oncology

Lung Cancer Mortality Mortality in the Lung Screening Study Feasibility Trial

Maryam Doroudi et al.

JNCI CANCER SPECTRUM (2018)

Add to Collection

Review Oncology

European position statement on lung cancer screening

Matthijs Oudkerk et al.

LANCET ONCOLOGY (2017)

Add to Collection

Article Respiratory System

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

Eugenio Paci et al.

THORAX (2017)

Add to Collection

Article Medicine, General & Internal

Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis

Cristiano Rampinelli et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Medicine, General & Internal

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada

Kevin ten Haaf et al.

PLOS MEDICINE (2017)

Add to Collection

Article Medicine, General & Internal

Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis

Cristiano Rampinelli et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Medicine, General & Internal

Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting

Marina Treskova et al.

BMC MEDICINE (2017)

Add to Collection

Article Critical Care Medicine

The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial

Nichole T. Tanner et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Add to Collection

Article Critical Care Medicine

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

Mathilde M. W. Wille et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Add to Collection

Editorial Material Oncology

Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco

Lisa M. Fucito et al.

CANCER (2016)

Add to Collection

Article Respiratory System

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial

Kate Brain et al.

THORAX (2016)

Add to Collection

Article Critical Care Medicine

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

Maurizio Infante et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Oncology

Lung Cancer Detectability by Test, Histology, Stage, and Gender: Estimates from the NLST and the PLCO Trials

Kevin ten Haaf et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Effect Modification of the Association of Cumulative Exposure and Cancer Risk by Intensity of Exposure and Time Since Exposure Cessation: A Flexible Method Applied to Cigarette Smoking and Lung Cancer in the SYNERGY Study

Jelle Vlaanderen et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)

Add to Collection

Article Oncology

Impact of Lung Cancer Screening Results on Participant Health-Related Quality of Life and State Anxiety in the National Lung Screening Trial

Ilana F. Gareen et al.

CANCER (2014)

Add to Collection

Article Medicine, General & Internal

Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer

Edward F. Patz et al.

JAMA INTERNAL MEDICINE (2014)

Add to Collection

Editorial Material Medicine, General & Internal

When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening

Peter B. Bach et al.

ANNALS OF INTERNAL MEDICINE (2012)

Add to Collection

Article Respiratory System

The impact of lung cancer on patients and carers

Jackie Ellis

CHRONIC RESPIRATORY DISEASE (2012)

Add to Collection

Article Respiratory System

Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial

K. A. M. van den Bergh et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Add to Collection

Article Medicine, General & Internal

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Denise R. Aberle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Article Oncology

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)

K. A. M. van den Bergh et al.

BRITISH JOURNAL OF CANCER (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.